These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Whole-exome sequencing reveals the spectrum of gene mutations and the clonal evolution patterns in paediatric acute myeloid leukaemia. Shiba N; Yoshida K; Shiraishi Y; Okuno Y; Yamato G; Hara Y; Nagata Y; Chiba K; Tanaka H; Terui K; Kato M; Park MJ; Ohki K; Shimada A; Takita J; Tomizawa D; Kudo K; Arakawa H; Adachi S; Taga T; Tawa A; Ito E; Horibe K; Sanada M; Miyano S; Ogawa S; Hayashi Y Br J Haematol; 2016 Nov; 175(3):476-489. PubMed ID: 27470916 [TBL] [Abstract][Full Text] [Related]
4. Oncogene Concatenated Enriched Amplicon Nanopore Sequencing for rapid, accurate, and affordable somatic mutation detection. Thirunavukarasu D; Cheng LY; Song P; Chen SX; Borad MJ; Kwong L; James P; Turner DJ; Zhang DY Genome Biol; 2021 Sep; 22(1):227. PubMed ID: 34482832 [TBL] [Abstract][Full Text] [Related]
5. Mutational spectrum and risk stratification of intermediate-risk acute myeloid leukemia patients based on next-generation sequencing. Wang B; Liu Y; Hou G; Wang L; Lv N; Xu Y; Xu Y; Wang X; Xuan Z; Jing Y; Li H; Jin X; Deng A; Wang L; Gao X; Dou L; Liang J; Chen C; Li Y; Yu L Oncotarget; 2016 May; 7(22):32065-78. PubMed ID: 27062340 [TBL] [Abstract][Full Text] [Related]
6. Accurate and Sensitive Analysis of Minimal Residual Disease in Acute Myeloid Leukemia Using Deep Sequencing of Single Nucleotide Variations. Delsing Malmberg E; Rehammar A; Pereira MB; Abrahamsson J; Samuelsson T; Ståhlman S; Asp J; Tierens A; Palmqvist L; Kristiansson E; Fogelstrand L J Mol Diagn; 2019 Jan; 21(1):149-162. PubMed ID: 30273780 [TBL] [Abstract][Full Text] [Related]
7. VarWalker: personalized mutation network analysis of putative cancer genes from next-generation sequencing data. Jia P; Zhao Z PLoS Comput Biol; 2014 Feb; 10(2):e1003460. PubMed ID: 24516372 [TBL] [Abstract][Full Text] [Related]
8. Clonal evolution of acute myeloid leukemia highlighted by latest genome sequencing studies. Zhang X; Lv D; Zhang Y; Liu Q; Li Z Oncotarget; 2016 Sep; 7(36):58586-58594. PubMed ID: 27474172 [TBL] [Abstract][Full Text] [Related]
10. Combined burden and functional impact tests for cancer driver discovery using DriverPower. Shuai S; ; Gallinger S; Stein LD; Nat Commun; 2020 Feb; 11(1):734. PubMed ID: 32024818 [TBL] [Abstract][Full Text] [Related]
11. Why Are Some Driver Mutations Rare? Nussinov R; Tsai CJ; Jang H Trends Pharmacol Sci; 2019 Dec; 40(12):919-929. PubMed ID: 31699406 [TBL] [Abstract][Full Text] [Related]
12. Variant allele frequencies do not correlate well with myeloblast counts in a clinically validated gene sequencing panel for routine acute myeloid leukemia workup. Toth LN; Green D; Peterson J; Deharvengt SJ; de Abreu FB; Loo EY Leuk Lymphoma; 2019 Oct; 60(10):2415-2422. PubMed ID: 30997856 [TBL] [Abstract][Full Text] [Related]